Physician profile
Anthony Yeung
NPI 1821034356
$16,762,552.78
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17M · 2020: $38K · 2021: $147 · 2022: $32.15 · 2023: $150 · 2024: $1,972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,192 · Travel and Lodging: $855 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,191.89 |
| Travel and Lodging | $854.70 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $16,721,999.00 | 2019 | |
| Richard Wolf Medical Instruments Corp. | $36,378.33 | 2020 | |
| Arthrex, INC. | $1,667.69 | 2024 | Arthrex |
| Aesculap, INC. | $1,054.63 | 2020 | |
| Surgalign Spine Technologies, INC. | $561.72 | 2019-2021 | |
| Integrity Implants INC. Dba Accelus | $304.00 | 2024 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $149.90 | 2023 | Uptravi, Opsumit |
| Integrity Implants INC. | $145.17 | 2020 | |
| Radius Health, INC. | $34.66 | 2019 | |
| Spine Wave, INC. | $32.15 | 2022 | |
| Baxter Healthcare | $24.82 | 2020 | |
| Boston Scientific Corporation | $11.91 | 2020 | |
| Forte Bio-Pharma LLC | $8.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$152,677.75 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Yeung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.